Here are the DEF 14A proxy statements from SeaStar Medical Holding Corporation (ICU) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ICU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ICU filings page.
SeaStar Medical Holding Corporation is asking stockholders to vote at its virtual 2026 annual meeting on four key items. Stockholders will elect one Class I director, John Neuman, to serve until the 2029 annual meeting, and vote on an expanded equity plan.
The company seeks approval to amend and restate its 2022 Equity Incentive Plan to increase authorized common shares under the plan from 207,046 to 896,546, following a 1-for-10 reverse stock split effective January 5, 2026. Stockholders will also vote on ratifying WithumSmith+Brown, PC as independent auditor for 2026 and on a possible adjournment of the meeting if more time is needed to gather votes. As of April 24, 2026, 3,997,002 shares of common stock were outstanding and entitled to one vote per share.
SeaStar Medical Holding Corporation (ICU) called a special stockholder meeting for December 18, 2025 at 10 am MST (virtual) to vote on capital structure changes. The Board seeks approval to effect a 1-for-10 reverse stock split of common stock at the Board’s discretion within one year, with fractional shares rounded up to the nearest whole share and no change to par value.
The Board also proposes reducing authorized common shares by 25,000,000 to 425,000,000, and an adjournment option if more time is needed to secure votes. The company cites Nasdaq’s $1.00 minimum bid requirement and potential delisting risk as key reasons to pursue the reverse split, noting the common stock closed at $0.5506 on November 3, 2025. Holders of record on November 3, 2025 may vote; 35,865,834 shares were outstanding as of that date. The Board recommends voting FOR all proposals.